Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,16
KB0,78
PKN67,4867,510,74
Msft449,7449,750,47
Nokia3,37153,5495-0,31
IBM172,08172,11-1,66
Mercedes-Benz Group AG64,7964,810,42
PFE28,0828,09-1,00
25.06.2024 19:47:46
Indexy online
AD Index online
select
AD Index online
 

  • 25.06.2024 18:46:21
Japan Unsp ADR (US Other OTC (Pink Sheets))
Poslední obchod Změna (%) Změna (USD) Objem obchodů (ks)
14,00 0,79 0,08 22 875
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 25.06.2024
Popis společnosti
Obecné informace
Název společnostiJapan Tobacco Inc - ADR
TickerJAPAY
Kmenové akcie:ADR
RICJAPAY.PK
ISIN-
Poslední známé roční výsledky31.12.2023
Poslední známé čtvrtletní výsledky31.03.2024
Počet zaměstnanců k 31.12.2023 53 239
Akcie v oběhu k 31.03.20241 775 341 636
MěnaJPY
Kontaktní informace
UliceKamiyacho Trust Tower, 4-1-1, Toranomon
MěstoMINATO-KU
PSČ105-6927
ZeměJapan
Kontatní osoba 
Funkce kontaktní osoby 
Telefon81 366 362 914
Fax81355721441

Business Summary: Japan Tobacco Inc is a Japan-based company mainly engaged in the tobacco business, the pharmaceutical business and the processed food business. The Company operates through four business segments. The Domestic Tobacco segment is engaged in the production and sale of manufactured tobacco in Japan (including domestic duty-free market and China, Hong Kong and Macao markets under the jurisdiction of China Business Division). The International Tobacco segment is engaged in the production and sale of manufactured tobacco overseas. The Medical segment is engaged in the research, development, production and sale of medical drugs. The Food Processing segment is engaged in the manufacture and sale of frozen and ambient temperature processed foods, bakery, seasoning, among others. The Company is also involved in the leasing of real estate.
Financial Summary: BRIEF: For the three months ended 31 March 2024, Japan Tobacco Inc - ADR revenues increased 11% to Y740.33B. Net income increased 9% to Y157.27B. Revenues reflect Domestic Tobacco segment increase of 13% to Y680.98B, Pharmaceutical Business segment increase of less than 1% to Y35.69B. Net income was partially offset by Tobacco overseas segment income decrease of 45% to Y3.84B, Other segment loss increase of 9% to Y11.07B.
Odvětvová klasifikace
TRBC2009Tobacco
TRBC2012Cigars & Cigarette Manufacturing
MGINDUSTRYTobacco
MGSECTORConsumer/Non-Cyclical
NAICSTobacco Manufacturing
NAICSPharmaceutical Preparation Manufacturing
NAICSFrozen Specialty Food Manufacturing
NAICSPerishable Prepared Food Manufacturing
NAICSCommercial Bakeries
NAICSSpice and Extract Manufacturing
NAICSLessors of Nonresidential Buildings (except Miniwarehouses)
NAICS2007Cigarette Mfg
NAICS2007Pharmaceutical Preparation Mfg
NAICS2007Soft Drink Mfg
NAICS2007Perishable Prepared Food Mfg
NAICS2007Fruit & Vegetable Canning
NAICS2007Spice & Extract Mfg
NAICS2007Other Tobacco Product Mfg
NAICS1997Cigarette Manufacturing
NAICS1997Pharmaceutical Preparation Manufacturing
NAICS1997Soft Drink Manufacturing
NAICS1997Perishable Prepared Food Manufacturing
NAICS1997Fruit and Vegetable Canning
NAICS1997Spice and Extract Manufacturing
NAICS1997Other Tobacco Product Manufacturing
SICCigarettes
SICPharmaceutical Preparations
SICFrozen Specialties, Nec
SICFood Preparations, Nec
SICBread, Cake And Related Products
SICNonresidential Building Operators



  • Poslední aktualizace: 25.06.2024
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
President, Chief Executive Officer, Executive Officer, Chief Director of Tobacco Business, Representative DirectorMasamichi Terabatake5801.01.2024
Executive Officer, Chief Financial OfficerHiromasa Furukawa-01.01.202401.01.2020
Vice President, Executive Officer, DirectorKei Nakano5601.01.2017
Senior Managing Executive Officer, Chief Executive Officer of Domestic Tobacco Business in Main Tabacco Business UnitJunichi Fukuchi-24.03.202122.06.2012
Executive OfficerIgor Dzaja-01.01.202401.01.2024
Executive Officer, Director of Pharmaceutical BusinessMuneaki Fujimoto-22.06.201222.06.2012
Executive OfficerTaku Fujiwara-01.01.202301.01.2023
Executive OfficerHiroyuki Fukuda-01.01.202301.10.2019
Executive OfficerOsamu Hirose-01.01.2020
Executive Officer, Chief Sustainability OfficerHisato Imokawa-01.01.202201.01.2020